Liposomal Irinotecan Plus Bevacizumab in Irinotecan-refractory Metastatic Colorectal Cancer

Clinical trial NCT06434090 · UNKNOWN

Trial details

NCT number: NCT06434090
Sponsor: Sun Yat-sen University
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Colorectal Cancer

Start date: 2024-06-05
Primary completion: 2025-06-05
Enrollment: 74

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.